Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses ———— — Research & development ———— — Operating income -2.12 M-17.48 M-39.31 M-5.76 M -64.67 M Non-Operating Income, Total ——-92 K-13.58 M — Interest expense, net of interest capitalized 2 M2 M1.9 M2 M 7.9 M Non-Operating Income, excl. Interest Expenses ——-1.99 M-15.58 M — Unusual income/expense ———— — Pretax income -943 K-11.13 M-39.72 M-5.97 M -57.76 M Equity in earnings ——218 K362 K — Taxes —400 K—— — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -934 K-13.44 M-39.77 M-5.97 M -60.11 M Discontinued operations ———— — Net income -934 K-13.44 M-39.77 M-5.97 M -60.11 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -934 K-13.44 M-39.77 M-5.97 M -60.11 M Basic earnings per share (Basic EPS) -0.27-1.64-4.15-0.51 -6.57 Diluted earnings per share (Diluted EPS) -0.27-1.64-4.15-0.51 -6.57 Average basic shares outstanding -14.75 M8.17 M8.6 M11.8 M — Diluted shares outstanding -14.75 M8.17 M8.6 M11.8 M — EBITDA -6.13 M-14.37 M-35.74 M-4.62 M -60.86 M EBIT -2.12 M-17.48 M-39.31 M-5.76 M -64.67 M Cost of revenue -1.06 M-2.12 M-833 K-1.93 M -5.94 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) -4.01 M3.1 M3.57 M1.14 M 3.8 M